Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för zofenoprilat. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

11 träffar

Bibliografisk träff 2013-10-01

Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis.

Marampon F, Gravina GL, Scarsella L, Festuccia C, Lovat F, Ciccarelli C, Zani BM, Zani BM, Polidoro L, Grassi D, Desideri G, Evangelista S, Ferri C.

J Hypertens · research support, non-u.s. gov't; journal article · DOI 10.1097/hjh.0b013e3283638b32

Bibliografisk träff 2013-08-18

The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis.

Monti M, Terzuoli E, Ziche M, Morbidelli L.

Pharmacol Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.phrs.2013.08.003

Bibliografisk träff 2011-02-17

Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of zofenopril and its active metabolite zofenoprilat in human plasma.

Jiang Y, Yan F, Di B, Feng F, You L, Huang L, Lu J.

J Pharm Biomed Anal · journal article · DOI 10.1016/j.jpba.2011.02.010

Bibliografisk träff 2010-10-05

Effects of zofenopril and ramipril on cough reflex responses in anesthetized and awake rabbits.

Mutolo D, Bongianni F, Evangelista S, Cinelli E, Pantaleo T.

J Cardiovasc Pharmacol Ther · research support, non-u.s. gov't; journal article · DOI 10.1177/1074248410379413

Bibliografisk träff 2009-11-01

Effects of zofenopril on cardiac sarcoplasmic reticulum calcium handling.

Frascarelli S, Carnicelli V, Ghelardoni S, Chiellini G, Ronca F, Zucchi R.

J Cardiovasc Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1097/fjc.0b013e3181be7597

Bibliografisk träff 2006-02-01

The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.

Lupi R, Del Guerra S, Bugliani M, Boggi U, Mosca F, Torri S, Del Prato S, Marchetti P.

Eur J Endocrinol · research support, non-u.s. gov't; journal article · DOI 10.1530/eje.1.02086

Bibliografisk träff 2000-12-01

Assay of zofenopril and its active metabolite zofenoprilat by liquid chromatography coupled with tandem mass spectrometry.

Dal Bo L, Mazzucchelli P, Marzo A.

J Chromatogr B Biomed Sci Appl · journal article · DOI 10.1016/s0378-4347(00)00419-9

Bibliografisk träff 1992-11-01

Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors.

Ranadive SA, Chen AX, Serajuddin AT.

Pharm Res · comparative study; journal article · DOI 10.1023/a:1015823315983

Bibliografisk träff 1992-01-01

The effect of bradykinin on coronary flow and its potentiation by SH-containing ACE-inhibitors.

de Graeff PA, van Gilst WH.

Agents Actions Suppl · review; journal article

Bibliografisk träff 1991-05-01

Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism.

van Wijngaarden J, Tio RA, van Gilst WH, de Graeff PA, de Langen CD, Wesseling H.

Naunyn Schmiedebergs Arch Pharmacol · comparative study; journal article · DOI 10.1007/bf00169551

Bibliografisk träff 1989-12-01

The haemodynamic effects of two angiotensin converting enzyme inhibitors, enalaprilat and zofenoprilat, in the rat: evidence for the involvement of bradykinin.

Tio RA, Heiligers JP, de Langen CD, van Gilst WH, König W, Saxena PR, Wesseling H.

J Hypertens Suppl · comparative study; journal article · DOI 10.1097/00004872-198900076-00144